1403 related articles for article (PubMed ID: 25935840)
1. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study.
Brueckmann B; Sasaki N; Grobara P; Li MK; Woo T; de Bie J; Maktabi M; Lee J; Kwo J; Pino R; Sabouri AS; McGovern F; Staehr-Rye AK; Eikermann M
Br J Anaesth; 2015 Nov; 115(5):743-51. PubMed ID: 25935840
[TBL] [Abstract][Full Text] [Related]
2. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
Flockton EA; Mastronardi P; Hunter JM; Gomar C; Mirakhur RK; Aguilera L; Giunta FG; Meistelman C; Prins ME
Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265
[TBL] [Abstract][Full Text] [Related]
3. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
Sacan O; White PF; Tufanogullari B; Klein K
Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
[TBL] [Abstract][Full Text] [Related]
4. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.
Jones RK; Caldwell JE; Brull SJ; Soto RG
Anesthesiology; 2008 Nov; 109(5):816-24. PubMed ID: 18946293
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults.
Hristovska AM; Duch P; Allingstrup M; Afshari A
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012763. PubMed ID: 28806470
[TBL] [Abstract][Full Text] [Related]
6. Reversal of rocuronium induced neuromuscular block with sugammadex or neostigmine: a large observational study.
Della Rocca G; Pompei L; Pagan DE Paganis C; Tesoro S; Mendola C; Boninsegni P; Tempia A; Manstretta S; Zamidei L; Gratarola A; Murabito P; Fuggiano L; DI Marco P
Acta Anaesthesiol Scand; 2013 Oct; 57(9):1138-45. PubMed ID: 23849107
[TBL] [Abstract][Full Text] [Related]
7. A comparison of sugammadex and neostigmine for reversal of rocuronium-induced neuromuscular blockade in children.
Ammar AS; Mahmoud KM; Kasemy ZA
Acta Anaesthesiol Scand; 2017 Apr; 61(4):374-380. PubMed ID: 28185260
[TBL] [Abstract][Full Text] [Related]
8. Randomized comparison of sugammadex and neostigmine for reversal of rocuronium-induced muscle relaxation in morbidly obese undergoing general anaesthesia.
Gaszynski T; Szewczyk T; Gaszynski W
Br J Anaesth; 2012 Feb; 108(2):236-9. PubMed ID: 22012861
[TBL] [Abstract][Full Text] [Related]
9. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.
Khuenl-Brady KS; Wattwil M; Vanacker BF; Lora-Tamayo JI; Rietbergen H; Alvarez-Gómez JA
Anesth Analg; 2010 Jan; 110(1):64-73. PubMed ID: 19713265
[TBL] [Abstract][Full Text] [Related]
10. The effect of residual neuromuscular blockade on the speed of reversal with sugammadex.
White PF; Tufanogullari B; Sacan O; Pavlin EG; Viegas OJ; Minkowitz HS; Hudson ME
Anesth Analg; 2009 Mar; 108(3):846-51. PubMed ID: 19224792
[TBL] [Abstract][Full Text] [Related]
11. Operating room discharge after deep neuromuscular block reversed with sugammadex compared with shallow block reversed with neostigmine: a randomized controlled trial.
Putz L; Dransart C; Jamart J; Marotta ML; Delnooz G; Dubois PE
J Clin Anesth; 2016 Dec; 35():107-113. PubMed ID: 27871505
[TBL] [Abstract][Full Text] [Related]
12. Use of sugammadex in patients with a history of pulmonary disease.
Amao R; Zornow MH; Cowan RM; Cheng DC; Morte JB; Allard MW
J Clin Anesth; 2012 Jun; 24(4):289-97. PubMed ID: 22608583
[TBL] [Abstract][Full Text] [Related]
13. Rocuronium blockade reversal with sugammadex vs. neostigmine: randomized study in Chinese and Caucasian subjects.
Wu X; Oerding H; Liu J; Vanacker B; Yao S; Dahl V; Xiong L; Claudius C; Yue Y; Huang Y; Abels E; Rietbergen H; Woo T
BMC Anesthesiol; 2014; 14():53. PubMed ID: 25187755
[TBL] [Abstract][Full Text] [Related]
14. Randomised controlled trial of sugammadex or neostigmine for reversal of neuromuscular block on the incidence of pulmonary complications in older adults undergoing prolonged surgery.
Togioka BM; Yanez D; Aziz MF; Higgins JR; Tekkali P; Treggiari MM
Br J Anaesth; 2020 May; 124(5):553-561. PubMed ID: 32139135
[TBL] [Abstract][Full Text] [Related]
15. Reversal of neuromuscular blockade with sugammadex at the reappearance of four twitches to train-of-four stimulation.
Pongrácz A; Szatmári S; Nemes R; Fülesdi B; Tassonyi E
Anesthesiology; 2013 Jul; 119(1):36-42. PubMed ID: 23665915
[TBL] [Abstract][Full Text] [Related]
16. Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
Abrishami A; Ho J; Wong J; Yin L; Chung F
Cochrane Database Syst Rev; 2009 Oct; (4):CD007362. PubMed ID: 19821409
[TBL] [Abstract][Full Text] [Related]
17. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
[TBL] [Abstract][Full Text] [Related]
18. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia.
Duvaldestin P; Kuizenga K; Saldien V; Claudius C; Servin F; Klein J; Debaene B; Heeringa M
Anesth Analg; 2010 Jan; 110(1):74-82. PubMed ID: 19933538
[TBL] [Abstract][Full Text] [Related]
19. Role of sugammadex in accelerating postoperative discharge: A meta-analysis.
Carron M; Zarantonello F; Lazzarotto N; Tellaroli P; Ori C
J Clin Anesth; 2017 Jun; 39():38-44. PubMed ID: 28494905
[TBL] [Abstract][Full Text] [Related]
20. Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies.
Herring WJ; Woo T; Assaid CA; Lupinacci RJ; Lemmens HJ; Blobner M; Khuenl-Brady KS
J Clin Anesth; 2017 Sep; 41():84-91. PubMed ID: 28802619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
